Cancer-Related Fatigue Support Protocol
Primary Stack
Core supplements with strongest evidenceAdaptogen that significantly reduces cancer-related fatigue in clinical trials
Supports mitochondrial energy production; may reduce chemotherapy-related fatigue
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsSupports cellular energy metabolism; may improve fatigue in cancer patients
Supporting Studies (1)
Deficiency common in cancer patients and associated with fatigue; supplementation may help
Supporting Studies (1)
Improves sleep quality and may reduce cancer-related fatigue
Supporting Studies (1)
Adaptogen that may improve fatigue and quality of life during cancer treatment
Supporting Studies (1)
Addresses cancer-related anemia which contributes to fatigue
Supporting Studies (1)
Support energy metabolism; deficiencies may contribute to fatigue
Supporting Studies (1)
Anti-inflammatory effects may help reduce systemic inflammation contributing to fatigue
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Cancer-related fatigue (CRF) is one of the most common and distressing symptoms experienced by cancer patients. Unlike ordinary tiredness, CRF is persistent, overwhelming exhaustion that is not relieved by rest. It can occur during treatment (chemotherapy, radiation) and may persist for months or even years after treatment ends. Multiple factors contribute: the cancer itself, treatment effects, anemia, inflammation, poor nutrition, sleep disturbances, and psychological factors.
CRITICAL: Cancer-related fatigue has many causes that should be evaluated medically, including anemia, thyroid dysfunction, electrolyte imbalances, and depression. These supplements support energy but don't replace treatment of underlying causes. Always discuss supplements with your oncology team.
* American Ginseng has the strongest evidence for cancer-related fatigue. A major clinical trial showed 2000mg daily significantly reduced fatigue in cancer patients, with benefits seen after 4-8 weeks. It works as an adaptogen to help the body cope with stress and may affect inflammatory cytokines that contribute to fatigue.
* Coenzyme Q10 supports mitochondrial energy production. Cancer and its treatments can impair mitochondrial function, and CoQ10 levels may be depleted by chemotherapy. Supplementation may help restore cellular energy production.
* L-Carnitine is essential for transporting fatty acids into mitochondria where they are burned for energy. Carnitine deficiency can develop during cancer treatment and contribute to fatigue. Supplementation may improve energy levels.
* Vitamin D deficiency is very common in cancer patients and independently associated with fatigue. Maintaining adequate levels may help improve energy and overall well-being.
* Melatonin helps with the sleep disturbances that are common during cancer treatment. Poor sleep significantly worsens fatigue, so improving sleep quality can have substantial benefits.
* Ashwagandha is an adaptogen that may help with fatigue and stress during cancer treatment, though evidence is still limited.
* Iron supplementation is essential if you have iron-deficiency anemia, which is common in cancer patients and directly causes fatigue. Your oncology team can check iron studies and determine if oral or IV iron is needed.
* B Vitamins support energy metabolism, and deficiencies may contribute to fatigue. A basic B-complex can help ensure adequate levels.
* Omega-3 Fatty Acids may help reduce the systemic inflammation that contributes to cancer-related fatigue.
Expected timeline: American ginseng: improvements in 4-8 weeks. CoQ10 and L-carnitine: 2-4 weeks. Iron (if deficient): several weeks. Melatonin: immediate sleep benefits. These supplements provide ongoing support throughout and after cancer treatment.
Clinical Perspective
Cancer-related fatigue (CRF) affects 80-90% of cancer patients during treatment and up to 40% after treatment. NCCN defines CRF as a distressing, persistent sense of tiredness related to cancer or its treatment that is not proportional to activity and interferes with function. Pathophysiology: multifactorial - pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha), hypothalamic-pituitary-adrenal axis dysfunction, serotonin dysregulation, skeletal muscle wasting, anemia, sleep-wake disruption. Contributing factors: treatment effects, anemia, thyroid dysfunction, depression, deconditioning, malnutrition, pain, medications.
CRITICAL: Evaluation should include: anemia (CBC), thyroid function (TSH), electrolytes, vitamin D, depression screening. First-line interventions: exercise (strongest evidence - even during treatment), cognitive-behavioral therapy, sleep hygiene. Treat underlying causes (anemia, depression, pain, sleep disorders). Supplements are adjunctive. Consider pharmaceutical options (psychostimulants) for severe refractory fatigue.
* American Ginseng (A-grade): Adaptogen; may modulate inflammatory cytokines (IL-6, TNF-alpha). NCCTG randomized trial: 2000mg daily significantly reduced fatigue vs placebo in cancer patients (PMID: 23853057). Systematic review confirms benefit (PMID: 30307164). 1000-2000mg daily. Generally safe; avoid with anticoagulants.
* CoQ10 (B-grade): Mitochondrial electron transport chain; chemotherapy may deplete levels. Clinical trial: CoQ10 improved fatigue in breast cancer patients (PMID: 28412964). 100-300mg daily. Ubiquinol form better absorbed.
* L-Carnitine (B-grade): Essential for fatty acid transport into mitochondria; deficiency common in cancer patients. Systematic review: L-carnitine may improve fatigue (PMID: 22936012). 1-3g daily. Well-tolerated.
* Vitamin D (B-grade): Deficiency very common (60-90%) in cancer patients; associated with fatigue. Systematic review: vitamin D supplementation may reduce CRF (PMID: 29099531). Check 25(OH)D; target 40-60 ng/mL. 2000-4000 IU daily.
* Melatonin (B-grade): Regulates sleep-wake cycle; antioxidant properties. Meta-analysis: melatonin improves sleep and reduces fatigue in cancer patients (PMID: 31729252). 3-20mg at bedtime.
* Ashwagandha (C-grade): Adaptogen; may reduce stress, support energy. Pilot study in cancer patients: improved fatigue and quality of life (PMID: 29927457). 300-600mg daily. Limited oncology data.
* Iron (B-grade): Treat iron-deficiency anemia (hemoglobin <12 g/dL, low ferritin). Review: iron supplementation improves anemia-related fatigue (PMID: 28494516). Oral vs IV based on severity, tolerance, treatment urgency. ESAs for chemotherapy-induced anemia per guidelines.
* B Vitamins (C-grade): Cofactors in energy metabolism. Review: deficiencies may contribute to fatigue; role of supplementation unclear (PMID: 26566928). B-complex providing 100% DV daily.
* Omega-3 Fatty Acids (C-grade): Anti-inflammatory effects. Systematic review: may help with inflammation-related symptoms (PMID: 27259980). 2-4g EPA+DHA daily.
Biomarker targets: Fatigue assessment scales (Brief Fatigue Inventory, FACIT-F), hemoglobin, ferritin, 25(OH)D, TSH, inflammatory markers (CRP), functional status, sleep quality assessment.
Protocol notes: Exercise is the most evidence-based intervention for CRF - recommend even during treatment (adapted to functional status). Sleep optimization critical. Screen and treat depression (bidirectional relationship with fatigue). Cognitive-behavioral therapy helps. Energy conservation strategies (activity pacing). Nutrition optimization. Address pain. Review medications for sedating effects. Psychostimulants (methylphenidate) for severe refractory fatigue - consider after addressing other causes. Steroids provide short-term energy boost but not sustainable. Survivorship care should continue to address fatigue - it can persist for years. Support groups may help. Mind-body practices (yoga, tai chi) have evidence. Coordinate supplement use with oncology team.